Standard-Lung Protective Ventilation for Acute Respiratory Distress Syndrome
This trial will study how different ventilator strategies impact the treatment of patients with acute respiratory failure on ECMO. Patients will be put into two groups and assigned different ventilator protocols to compare the effects.
- Acute Respiratory Distress Syndrome (ARDS)
- Acute Respiratory Failure
1 Primary · 7 Secondary · Reporting Duration: From study enrollment until hospital discharge or death, whichever comes first, up to 52 weeks
2 Treatment Groups
Standard-Lung Protective Ventilation
1 of 2
Ultra-Lung Protective Ventilation
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: Standard-Lung Protective Ventilation · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are individuals being accepted to participate in this investigation currently?
"According to the clinicaltrials.gov database, this research is actively looking for volunteers as of March 1st 2023; a date that coincides with its last update on the same day." - Anonymous Online Contributor
What is the current scope of participants in this clinical trial?
"Confirmed. Clinicaltrials.gov demonstrates that this medical research was first launched on March 1st, 2023 and is still recruiting participants. At present, the trial requires a total of twenty individuals from one single site to join in." - Anonymous Online Contributor